Doximity, Inc. (DOCS)
Company Info
US26622P1075
26622P107
Jun 24, 2021
Highlights
$9.76B
$1.11
46.79
3.01
$570.40M
$514.53M
$231.92M
$25.00 - $85.21
$60.88
7.11%
4.23
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Doximity, Inc. (DOCS) returned -2.43% year-to-date (YTD) and 87.71% over the past 12 months.
DOCS
-2.43%
-8.42%
-1.72%
87.71%
14.18%
N/A
N/A
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of DOCS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 10.69% | 19.29% | -17.69% | -1.98% | -8.42% | -2.43% | |||||||
| 2024 | -3.89% | 4.75% | -4.68% | -9.74% | 14.16% | 0.87% | 0.11% | 31.36% | 18.46% | -4.20% | 26.98% | 0.74% | 90.41% |
| 2023 | 5.10% | -4.65% | -3.72% | 13.50% | -16.54% | 10.92% | 5.03% | -33.28% | -10.99% | -3.72% | 13.80% | 20.60% | -16.45% |
| 2022 | -9.10% | 34.63% | -15.09% | -23.46% | -12.24% | -0.49% | 21.54% | -21.57% | -8.95% | -12.41% | 28.41% | -1.27% | -33.05% |
| 2021 | 9.81% | 6.36% | 48.63% | -12.28% | -13.90% | -2.63% | -25.90% | -5.42% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 87, DOCS is among the top 13% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Doximity, Inc. (DOCS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Doximity, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Doximity, Inc. was 80.53%, occurring on Sep 26, 2023. The portfolio has not yet recovered.
The current Doximity, Inc. drawdown is 48.94%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -80.53% | Sep 13, 2021 | 513 | Sep 26, 2023 | — | — | — |
| -21.26% | Jul 27, 2021 | 9 | Aug 6, 2021 | 3 | Aug 11, 2021 | 12 |
| -19.76% | Jun 29, 2021 | 5 | Jul 6, 2021 | 12 | Jul 22, 2021 | 17 |
| -12.81% | Aug 26, 2021 | 1 | Aug 26, 2021 | 5 | Sep 2, 2021 | 6 |
| -7.11% | Aug 17, 2021 | 3 | Aug 19, 2021 | 2 | Aug 23, 2021 | 5 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Doximity, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Doximity, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 39.2% positive surprise.
Valuation
The Valuation section provides an overview of how Doximity, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for DOCS, comparing it with other companies in the Health Information Services industry. Currently, DOCS has a P/E ratio of 46.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for DOCS compared to other companies in the Health Information Services industry. DOCS currently has a PEG ratio of 3.0. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for DOCS relative to other companies in the Health Information Services industry. Currently, DOCS has a P/S ratio of 17.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DOCS in comparison with other companies in the Health Information Services industry. Currently, DOCS has a P/B value of 9.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |